Lipid-lowering PCSK9 sequence variants protect against coronary heart disease
This article has no abstract so we have provided the first paragraph of the full text.
Although genetic studies might help to clarify whether low LDL cholesterol levels confer protection against coronary heart disease (CHD), disorders in which LDL cholesterol levels are substantially lowered seem to be genetically heterogeneous.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Cholesterol, racial variation and targeted medicinesNature Medicine News and Views (01 Feb 2005)
